1. Cardiorespiratory management of infants born at 22 weeks' gestation: The Iowa approach
- Author
-
Mba Ram Niwas Mbbs, Mph Tarah T. Colaizy Md, Ana Tracey Morgan-Harris, Heidi M. Harmon, Robert D. Roghair, Mbbs Sunny Arikat, Mph Julie B. Lindower Md, DO Timothy J. Boly, Adrianne Rahde Bischoff, Matthew A. Rysavy, Samuel W. Wong Do, Danielle R. Rios, Jennifer R. Bermick, Stephanie S. Lee, DO Timothy G. Elgin, Edward F. Bell, Paeds) Patrick J. McNamara MBBCh, Jeffrey L. Segar, Brady A. Thomas, Jonathan M. Klein, Steve J. McElroy, Regan E. Giesinger, Stephen K. Hunter, John M. Dagle, and Mme Glenda K. Rabe Md
- Subjects
medicine.medical_specialty ,business.industry ,Standardized approach ,Psychological intervention ,Infant, Newborn ,Parturition ,Obstetrics and Gynecology ,Cardiorespiratory fitness ,Sequela ,Gestational Age ,Infant, Premature, Diseases ,medicine.disease ,Iowa ,Patient population ,Pregnancy ,Pediatrics, Perinatology and Child Health ,medicine ,Gestation ,Vulnerable population ,Humans ,Female ,Clinical care ,Intensive care medicine ,business ,Infant, Premature - Abstract
The approach to clinical care of infants born at 22 weeks’ gestation must be consistent and well-designed if optimal results are to be expected. Publications from several international centers have demonstrated that, although there may be variance in aspects of care in this vulnerable population, treatment should be neither random nor inconsistent. In designing a standardized approach, careful attention should be paid to the unique anatomy, physiology, and biochemistry of this vulnerable patient population. Emerging evidence, suggesting a link between cardiopulmonary health and longer-term sequela, highlights the importance of understanding the relationship between cardiorespiratory illnesses of the 22-week infant, treatments provided, and subsequent cardiopulmonary development. In this review we will provide an overview to our approach to cardiopulmonary assessment and treatment, with a particular emphasis on the importance of early recognition of atypical phenotypes, timely interventions with evidence-based treatments, and longitudinal monitoring.
- Published
- 2021